These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant. Reynolds JL; Ignatowski TA; Sud R; Spengler RN J Pharmacol Exp Ther; 2004 Sep; 310(3):1216-25. PubMed ID: 15082752 [TBL] [Abstract][Full Text] [Related]
4. Effect of tumor necrosis factor-alpha on the reciprocal G-protein-induced regulation of norepinephrine release by the alpha2-adrenergic receptor. Reynolds JL; Ignatowski TA; Spengler RN J Neurosci Res; 2005 Mar; 79(6):779-87. PubMed ID: 15672410 [TBL] [Abstract][Full Text] [Related]
5. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Reynolds JL; Ignatowski TA; Sud R; Spengler RN Neuroscience; 2005; 133(2):519-31. PubMed ID: 15878644 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Campana WM; Li X; Shubayev VI; Angert M; Cai K; Myers RR Eur J Neurosci; 2006 Feb; 23(3):617-26. PubMed ID: 16487143 [TBL] [Abstract][Full Text] [Related]
7. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. George A; Schmidt C; Weishaupt A; Toyka KV; Sommer C Exp Neurol; 1999 Nov; 160(1):124-32. PubMed ID: 10630197 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Uçeyler N; Göbel K; Meuth SG; Ortler S; Stoll G; Sommer C; Wiendl H; Kleinschnitz C Exp Neurol; 2010 Mar; 222(1):153-60. PubMed ID: 20051242 [TBL] [Abstract][Full Text] [Related]
9. Uncovering molecular elements of brain-body communication during development and treatment of neuropathic pain. Sud R; Ignatowski TA; Lo CP; Spengler RN Brain Behav Immun; 2007 Jan; 21(1):112-24. PubMed ID: 16859892 [TBL] [Abstract][Full Text] [Related]
10. Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release. Spengler RN; Sud R; Knight PR; Ignatowski TA Neuropharmacology; 2007 Feb; 52(2):576-89. PubMed ID: 17055005 [TBL] [Abstract][Full Text] [Related]
11. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model. Zanella JM; Burright EN; Hildebrand K; Hobot C; Cox M; Christoferson L; McKay WF Spine (Phila Pa 1976); 2008 Feb; 33(3):227-34. PubMed ID: 18303453 [TBL] [Abstract][Full Text] [Related]
12. Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Guneli E; Onal A; Ates M; Bagriyanik HA; Resmi H; Orhan CE; Kolatan HE; Gumustekin M Neurosci Lett; 2010 Aug; 479(3):226-30. PubMed ID: 20561937 [TBL] [Abstract][Full Text] [Related]
13. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain. Sato C; Sakai A; Ikeda Y; Suzuki H; Sakamoto A Anesth Analg; 2008 Jan; 106(1):313-20, table of contents. PubMed ID: 18165597 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. De Vry J; Kuhl E; Franken-Kunkel P; Eckel G Eur J Pharmacol; 2004 May; 491(2-3):137-48. PubMed ID: 15140630 [TBL] [Abstract][Full Text] [Related]
15. Sildenafil induces hyperalgesia via activation of the NO-cGMP pathway in the rat neuropathic pain model. Patil CS; Padi SV; Singh VP; Kulkarni SK Inflammopharmacology; 2006 Mar; 14(1-2):22-7. PubMed ID: 16835709 [TBL] [Abstract][Full Text] [Related]
16. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Song XS; Cao JL; Xu YB; He JH; Zhang LC; Zeng YM Acta Pharmacol Sin; 2005 Jul; 26(7):789-98. PubMed ID: 15960884 [TBL] [Abstract][Full Text] [Related]
17. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Costa B; Trovato AE; Comelli F; Giagnoni G; Colleoni M Eur J Pharmacol; 2007 Feb; 556(1-3):75-83. PubMed ID: 17157290 [TBL] [Abstract][Full Text] [Related]
18. Transient early expression of TNF-alpha in sciatic nerve and dorsal root ganglia in a mouse model of painful peripheral neuropathy. Sacerdote P; Franchi S; Trovato AE; Valsecchi AE; Panerai AE; Colleoni M Neurosci Lett; 2008 May; 436(2):210-3. PubMed ID: 18394803 [TBL] [Abstract][Full Text] [Related]
19. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain. Zhu J; Wei X; Feng X; Song J; Hu Y; Xu J Neurosci Lett; 2008 Mar; 433(1):33-7. PubMed ID: 18248895 [TBL] [Abstract][Full Text] [Related]
20. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Holdridge SV; Cahill CM Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]